
Refactor
Description
Refactor Capital is a prominent seed-stage venture capital firm based in Burlingame, California, dedicated to investing in companies at the forefront of bio, climate, and hard tech innovation. Founded by Zack Bogue and Tige Savage, the firm leverages its partners' extensive experience in technology and finance to identify and nurture startups with the potential for significant, long-term impact. Refactor distinguishes itself by focusing on foundational technologies that address pressing global challenges, seeking out companies with strong scientific or engineering defensibility.
The firm's investment strategy centers on providing the crucial first institutional capital to early-stage companies. Refactor typically writes initial checks ranging from $500,000 to $2,000,000, aiming to be a lead investor or a significant participant in seed rounds. Beyond capital, Refactor adopts a hands-on approach, working closely with founders to navigate the complexities of product development, market entry, and team building. Their operational expertise and robust network are critical resources for portfolio companies as they scale from concept to commercialization.
Refactor Capital has demonstrated a consistent growth in its capital base, reflecting its successful investment thesis and increasing influence in the deep tech ecosystem. The firm raised a $50 million Fund I, followed by a $100 million Fund II. Most recently, Refactor closed its Fund III in 2022, securing $150 million in commitments. This latest fund brings their total assets under management to approximately $300 million, enabling them to support a growing portfolio of high-potential ventures and participate in follow-on rounds as their companies mature.
The firm's portfolio showcases its commitment to backing ambitious founders who are developing proprietary solutions across diverse sectors, including advanced materials, synthetic biology, renewable energy, and artificial intelligence applied to complex physical problems. Refactor's disciplined focus on technically challenging, capital-intensive sectors underscores its belief that breakthrough innovations in these areas are essential for shaping the future and delivering substantial returns.
Investor Profile
Refactor has backed more than 88 startups, with 6 new investments in the last 12 months alone. The firm has led 15 rounds, about 17% of its total and boasts 10 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom.
- Strong thematic focus on Health Care, Biotechnology, Medical.
- Led 2 rounds in the past year.
- Typical check size: $500K – $2M.
Stage Focus
- Seed (52%)
- Series A (25%)
- Series B (9%)
- Series C (3%)
- Series D (3%)
- Pre Seed (3%)
- Series Unknown (3%)
Country Focus
- United States (98%)
- United Kingdom (2%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Internet
- Life Science
- Health Diagnostics
- Manufacturing
- Pharmaceutical
- Genetics
- Biopharma
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.